0000914190-16-000760.txt : 20160822
0000914190-16-000760.hdr.sgml : 20160822
20160822171152
ACCESSION NUMBER: 0000914190-16-000760
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160818
FILED AS OF DATE: 20160822
DATE AS OF CHANGE: 20160822
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kummeth Charles R.
CENTRAL INDEX KEY: 0001534980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 161845883
MAIL ADDRESS:
STREET 1: 425 MARTINGALE ROAD
STREET 2: SUITE 1000
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173-2213
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-08-18
0000842023
BIO-TECHNE Corp
TECH
0001534980
Kummeth Charles R.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
1
1
0
0
Chief Executive Officer
Common Stock
2016-08-18
4
A
0
16653
0
A
61030
D
Stock Option (Right to Buy)
67.46
2020-04-01
Common Stock
65000
65000
D
Stock Option (Right to Buy)
67.46
2020-04-01
Common Stock
50000
50000
D
Stock Option (Right to Buy)
86.25
2021-04-01
Common Stock
46316
46316
D
Stock Option (Right to Buy)
94.35
2021-08-12
Common Stock
80460
80460
D
Restricted Stock Unit
Common Stock
11129
11129
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
79517
79517
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
119275
119275
D
Restricted Stock Unit
Common Stock
17283
17283
D
Stock Option (Right to Buy)
106.59
2016-08-18
4
A
0
102779
0
A
2023-08-18
Common Stock
102779
102779
D
Stock Option (Right to Buy)
106.59
2016-08-18
4
A
0
154169
0
A
2023-08-18
Common Stock
154169
154169
D
Restricted Stock Unit
2016-08-18
4
A
0
24979
0
A
Common Stock
24979
24979
D
Includes (i) 2,551 shares for which the risk of forfeiture will lapse with respect to 2,551 shares on April 1, 2017; (ii) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (iii) 7,682 shares for which the risks of forfeiture will lapse with respect to 3,841 shares on each of August 7, 2017 and August 7, 2018; and (iv) 16,653 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2017, August 18, 2018 and August 18, 2019.
The option will vest pursuant to the following schedule: 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending March 1, 2017, and 1,361 shares on April 1, 2017.
Fully exercisable pursuant to achievement of performance goals.
The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018.
Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years.
19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20.
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
/s/ Elizabeth M. Dunshee as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed.
2016-08-22